title: Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease.
abstract: Sickle cell anemia (HbSS) includes chronic inflammation, but the origin is unclear. We hypothesized that in stable HbSS patients the inflammation was associated with hypermetabolism. We compared selected hypermetabolic and key immunomodulator indicators in HbSS versus control children and examined associations between measures of hypermetabolism and inflammation. Twelve fasting asymptomatic HbSS children 6-12 years and 9 controls matched for age, gender and fat mass (FM) were studied. Proportional reticulocyte count (retic%) and resting energy expenditure (REE) represented hypermetabolism, and C-reactive protein (CRP) indicated inflammation. Proinflammatory cytokines tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), chemokine monocyte chemoattractant protein-1 (MCP-1), and energy balance cytokine leptin were measured. Methods were indirect calorimetry, enzyme-linked immunosorbent assay, and radioimmunoassay. Statistical analysis included simple correlation and regression analysis. REE (51 +/- 6 vs. 43 +/- 12 kcal/kg per fat-free mass (FFM), mean +/- SD), retic% (12 +/- 4 vs. 0.7 +/- 0.3%), CRP (5 +/- 3 vs. 0.3 +/- 0.4 mg/liter), and IL-6 (71 +/- 40 vs. 20 +/- 7 pg/ml) were significantly higher for HbSS than controls (P < 0.05). Conversely, leptin (0.1 +/- 0.1 vs. 2 +/- 1 microg/liter per kgFM) and MCP-1 (34 +/- 5 vs. 41 +/- 4 pg/ml) were significantly lower for the HbSS subjects (P < 0.01). TNF-alpha was not significantly different. There were no significant associations between REE or retic% and any cytokine measured. However, CRP was significantly associated with REE in HbSS (r = 0.8, P = 0.003) and an important predictor of REE/FFM. We provide new evidence for low circulating levels of inflammatory chemokine MCP-1 in stable HbSS children, confirm mostly low cytokine levels, inflammation, and hypermetabolism and demonstrate association of hypermetabolism with inflammation via CRP but not via cytokines.
authors.affiliation: Microbiology/Biochemistry/Immunology/Pediatrics, Morehouse School of Medicine, 720 Westview Drive, S.W., Atlanta, Georgia 30310-1495, USA. hibberj@msm.edu
authors.forename: Jacqueline M
authors.initials: JM
authors.lastname: Hibbert
authors.forename: Lewis L
authors.initials: LL
authors.lastname: Hsu
authors.forename: Sam J
authors.initials: SJ
authors.lastname: Bhathena
authors.forename: Ikovwa
authors.initials: I
authors.lastname: Irune
authors.forename: Bismark
authors.initials: B
authors.lastname: Sarfo
authors.forename: Melissa S
authors.initials: MS
authors.lastname: Creary
authors.forename: Beatrice E
authors.initials: BE
authors.lastname: Gee
authors.forename: Ali I
authors.initials: AI
authors.lastname: Mohamed
authors.forename: Iris D
authors.initials: ID
authors.lastname: Buchanan
authors.forename: Ahmad
authors.initials: A
authors.lastname: Al-Mahmoud
authors.forename: Jonathan K
authors.initials: JK
authors.lastname: Stiles
mesh_terms: D000755:Anemia, Sickle Cell / Q000097:blood*; D001823:Body Composition; D002097:C-Reactive Protein / Q000378:metabolism; D002648:Child; D016207:Cytokines / Q000097:blood*; D005260:Female; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood*; D008297:Male
chemical_list: D016207:Cytokines; D018836:Inflammation Mediators; D002097:C-Reactive Protein